Startup · $23.1m raised · Healthcare
Adelaide, SA
Every investor coverage indicates participated in a round Ferronova raised.
| Investor | Rounds | Invested |
|---|---|---|
| UniSuper | Series A | - |
| Uniseed/UniSuper | Series A | - |
| Uniseed | Series A · Series A · Series A | - |
| Stoic Venture Capital | Series A | - |
| South Australian Venture Capital Fund | Series A | - |
| Renew Pharmaceuticals | Series A · Series A | $8,000,000 |
| Previously existing shareholders | Series A | - |
| Internal investors | Series A | $6,000,000 |
| Existing investors | Series A | - |
| Cooperative Research Centre | Series A | $3,000,000 |
| Australian government Co-Operative Research Center | Series A | - |
| Artesian VC | Series A · Series A | - |
Companies Ferronova acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Ferronova. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Wholesale Investor's Steve Torso highlights Australian life sciences companies from the Emergence Preview Series, noting government grant funding, a Series A extension, venture co-investment, and a medtech company's ASX listing.
Also Wholesale Investor
Roundup of seven trans-Tasman raises worth $93.1m this week, headlined by IND Technology's $50m round, with LawVu also acquiring ClauseBase.
Uniseed's site carries a short announcement that Ferronova has secured a further $6 million for its surgical imaging technology used in cancer operations.
Also biospectrumasia.com·Business News Australia·Biotech Dispatch·SmartCompany·Startup Daily·Startup Daily·Wholesale Investor·Wholesale Investor
Adelaide biotech Ferronova added $6 million to its Series A from prior backers, lifting the round's total to $17.5 million; backer Renew's parent Ultragreen.ai floated in Singapore this month.
Also ferronova.com.au·movefm.com.au·Biotech Dispatch·Startup Daily
Weekly roundup covering three Australian raises: Rumin8's climate tech funding led by Breakthrough Energy Ventures, Ferronova's biotech round led by Renew Pharmaceuticals, and EMVision's stroke imaging milestone payment.
Adelaide biotech Ferronova raised $11 million for its cancer-detection nanotechnology, with Renew Pharmaceuticals and a government CRC contributing, following an earlier $4.6 million Series A in 2020.
Also SmartCompany
Adelaide cancer-focused biotech Ferronova has secured fresh backing: an investor round led by Irish strategic partner Renew Pharmaceuticals plus a federal research grant, to speed clinical trials in stomach and brain cancers.
Also SmartCompany·SmartCompany·SmartCompany·Startup Daily·Business News Australia·Startup Daily
Biotech startup Ferronova closed a $3.5 million Series A led by Stoic Venture Capital to commercialise iron nanoparticle technology for cancer diagnosis and treatment.
Cancer-detection nanotech developer Ferronova announced a $3.5 million Series A round, with Uniseed leading, to fund planned human trials across several cancer types; research partners span four universities.